Apothecary Pharma LLC recalls Tirzepatide Injection

Recalling company

Apothecary Pharma LLC

Product

Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC 27513, NDC 85091-001-18.

Reason

Lack of Assurance of Sterility

Classification

Class II – may cause temporary or medically reversible health consequences

Recall date

Sep 24, 2026

Reported

Oct 14, 2026

Distribution

Nationwide within the United States

Status

Ongoing

Quantity

22 vials

Lot / codes

Lot #: AP-202622, BUD 07-Oct-2026; AP-202623, BUD 08-Oct-2026; AP-202624, BUD 19-Oct-2026; AP-202625, BUD 10/20/2026; AP-202627, BUD 10/26/2026; AP-202628, BUD 10/27/2026; AP-202629, BUD 10/28/2026; AP-202630, BUD 10/31/2026; AP-202631, BUD 11/01/2026; AP-202632, BUD 11/03/2026; AP-202633, BUD 11/07/2026; AP-202634, BUD 11/08/2026; AP-202635, BUD 11/16/2026; AP-202636, BUD 11/17/2026; AP-202637,BUD 11/18/2026; AP-202638, BUD 11/19/2026; AP-202639, BUD 11/20/2026; AP-202640, BUD 11/21/2026;AP-202641, BUD 11/22/2026; AP-202642, BUD 11/24/2026; AP-202643, BUD 11/25/2026; AP-202644, BUD 11/26/2026

Company location

Cary, NC

Recall type

Voluntary: Firm initiated

Recall number

D-0036-2027

Agency

U.S. Food and Drug Administration (FDA)

View official FDA notice ↗ Search recall number D-0036-2027 in the FDA Enforcement Report. Also see FDA recall press releases.